Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Polio Vaccines (OPV and IPV) Market to 2022 - Market to Grow at a CAGR of 17.65% - ResearchAndMarkets.com

Research and Markets
Posted on: 25 Oct 18

The "Global Polio Vaccines Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global Polio Vaccines Market to grow at a CAGR of 17.65% during the period 2018-2022.

Polio is a highly contagious disease caused by a human enterovirus of the Picornaviridae family, resulting in paralysis or death. Two types of polio vaccination are available, OPV and IPV. The incidence of polio has been decreasing owing to initiatives by governments globally to drive immunization against the infection. The report covers the present scenario and the growth prospects of the polio vaccines market. To calculate the market size, the report considers the revenue generated from the retail sales of polio vaccines across the globe. The report also includes a discussion of the Key vendors operating in this market.

According to the report, one driver influencing this market is the increased funding for the development of various types of polio vaccine. The global polio vaccines market has been witnessing rise in number of immunizations drives by government bodies, increased funding for polio vaccine supply, and innovative delivery systems.

One trend affecting this market is the cessation of oral polio vaccine. There is a growing need for cessation of OPV because the use of OPV can result in cases of polio due to circulating VDPV and vaccine-associated paralytic polio as oral vaccines contain weakened polioviruses.

Further, the report states that one challenge affecting this market is the lack of effective cold chain logistic. Polio vaccines require a highly maintained cold chain logistics and most countries lack effective cold chain logistic and a proper vaccine management system.

Key vendors

  • Astellas Pharma
  • GlaxoSmithKline
  • Sanofi
  • Serum Institute of India

Key Topics Covered:

01: Executive Summary

02: Scope Of The Report

03: Research Methodology

04: Market Landscape

05: Pipeline Analysis

06: Market Sizing

07: Five Forces Analysis

08: Market Segmentation By Vaccine Type

09: Customer Landscape

10: Regional Landscape

11: Decision Framework

12: Drivers And Challenges

13: Market Trends

14: Vendor Landscape

15: Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/ptv5bx/global_polio?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181025005479/en/

Business Wire
www.businesswire.com

Last updated on: 25/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.